20世纪初期,已经证实免疫学方法可使肿瘤患者的肿瘤生长延缓,或使恶性肿瘤消退。因此,免疫治疗虽不是一门新的医学科学,但只是在近来由于很多试验的结果使其作为控制癌肿的一个新途径。本文将综述实体肿瘤和淋巴瘤的免疫治疗和化学治疗的有关试验。 恶性黑色素瘤 在肿瘤的免疫学方法中,研究得最多的是恶性黑色素瘤。1971年,作者首先对人类弥漫性实体癌大规模进行免疫治疗联合化疗,应用氨基甲酰异吡唑 Early twentieth Century, has proven immunological methods can delay tumor growth in patients with cancer, or regression of malignant tumors. Therefore, although immunotherapy is not a new medical science, it has only recently been used as a new way to control cancer due to the results of many trials. This article reviews the relevant trials of immunotherapy and chemotherapy for solid tumors and lymphomas. Malignant melanoma The most studied of the immunological approaches to tumors is malignant melanoma. In 1971, the author of large-scale human diffuse solid cancer immunotherapy combined with chemotherapy, application of carbamoyl isopyrazole